GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,010,000 | +11.4% | 500,000 | +16.3% | 2.74% | +66.9% |
| Q1 2019 | $17,970,000 | +51.7% | 430,000 | +38.7% | 1.64% | +22.8% |
| Q4 2018 | $11,845,000 | -65.9% | 310,000 | -64.2% | 1.34% | -66.5% |
| Q3 2018 | $34,747,000 | +12.7% | 865,000 | +13.1% | 3.99% | -6.2% |
| Q2 2018 | $30,837,000 | +57.9% | 765,000 | +53.0% | 4.25% | +43.3% |
| Q1 2018 | $19,535,000 | +22.4% | 500,000 | +11.1% | 2.97% | +58.4% |
| Q4 2017 | $15,962,000 | -12.6% | 450,000 | 0.0% | 1.87% | -28.2% |
| Q3 2017 | $18,270,000 | -5.8% | 450,000 | 0.0% | 2.61% | -20.9% |
| Q2 2017 | $19,404,000 | +203.6% | 450,000 | +13.0% | 3.30% | +98.7% |
| Q2 2016 | $6,391,000 | +52.3% | 398,287 | +305.6% | 1.66% | +132.0% |
| Q4 2014 | $4,197,000 | -6.0% | 98,200 | +1.1% | 0.72% | +29.8% |
| Q3 2014 | $4,464,000 | -72.2% | 97,100 | -67.6% | 0.55% | -86.1% |
| Q2 2014 | $16,044,000 | -53.8% | 300,000 | -53.8% | 3.95% | -50.1% |
| Q1 2014 | $34,730,000 | +18.3% | 650,000 | +18.2% | 7.93% | -3.1% |
| Q4 2013 | $29,365,000 | – | 550,000 | – | 8.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |